Archive for the ‘Food Safety News’ category

Statement from FDA Commissioner Scott Gottlieb, M.D., on the Funding Awards to States for FDA Food Safety Modernization Act (FSMA) Produce Safety Implementation

July 19, 2017

More than 3,000 Americans are estimated to die each year from foodborne illnesses and many more are hospitalized and sickened. Yet most of these illnesses and deaths are preventable. While the U.S. has one of the safest food supplies in the world, Congress entrusted the FDA with new authorities and resources – as part of […]

FDA approves Vosevi for Hepatitis C

July 18, 2017

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

FDA approves new treatment to reduce the risk of breast cancer returning

July 17, 2017

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back. […]

Bestherbs Coffee LLC Issues Voluntary Nationwide Recall of New Kopi Jantan Tradisional Natural Herbs Coffee due to the Presence of Undeclared Active Pharmaceutical Ingredients and Undeclared Milk

July 17, 2017

Grand Priarie, TX, Bestherbs Coffee LLC is voluntarily recalling all lots of New of Kopi Jantan Tradisional Natural Herbs Coffee, 13 grams to the consumer level. FDA laboratory analysis confirmed the presence of desmethyl carbodenafil. Desmethyl carbodenafil is structurally similar to sildenafil, the active ingredient in Viagra, an FDA-approved prescription drug for erectile dysfunction (ED). […]

Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse

July 13, 2017

In March 2016, the FDA asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to outline the state of the science regarding prescription opioid abuse and misuse, as well as the evolving role that opioids play in pain management. We greatly appreciate all the work done by NASEM over the past year to produce […]

Statement from Alberto Gutierrez, Ph.D., Director, Office of In Vitro Diagnostics and Radiological Health, FDA’s Center for Devices and Radiological Health on the status of FDA’s investigation into inaccurate results from certain lead tests

July 13, 2017

On May 17, the U.S. Food and Drug Administration warned Americans that Magellan Diagnostics’ LeadCare test systems performed on blood drawn from the vein (venous) may provide inaccurate results.

FDA approves new treatment for sickle cell disease

July 7, 2017

The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

Federal judge enters consent decree against Alabama compounder Medistat

July 6, 2017

U.S. District Judge William H. Steele entered a consent decree of permanent injunction yesterday between the United States and Medistat RX LLC of Foley, Alabama, the company’s co-owners, Mark D. Acker and Timothy L. Fickling, and quality manager and pharmacist-in-charge V. Elaine Waller.

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

July 3, 2017

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.

Federal judge orders New York smoked fish company to stop sales due to food safety violations

June 30, 2017

A New York smoked fish company has been ordered by a federal court to stop selling its products, which were produced in a facility that was contaminated with Listeria monocytogenes (L. mono), until it can comply with food safety regulations.

FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas

June 29, 2017

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

FDA unveils plan to eliminate orphan designation backlog

June 29, 2017

Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency’s existing orphan designation request backlog and ensure continued timely response to all new requests for designation with firm deadlines. The agency’s Orphan Drug Modernization Plan comes a week after FDA Commissioner Scott Gottlieb committed to eliminating the backlog within 90 […]

FDA Tackles Drug Competition to Improve Patient Access

June 27, 2017

Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to expedite the review […]

Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs

June 26, 2017

In late 2012, the United States faced the most serious outbreak associated with contaminated compounded drugs in recent history, involving hundreds of people, in many states, who developed fungal infections related to a compounded product. It was an incident that resulted in dozens of deaths.

FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

June 22, 2017

The U.S. Food and Drug Administration today approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients. The subcutaneous route of administration allows for easier at-home self-injection by the patient or caregiver, once proper training is received.

United Natural Trading LLC Announces Voluntary Recall of Products Containing Organic and Natural Chopped Dates Due to Possible Health Risk

June 20, 2017

United Natural Trading LLC, Edison, NJ, is voluntarily recalling a limited number of products containing Organic and Natural dates (see below) and sold under the Nature’s Promise, Woodstock, Market Basket, and Wholesome Pantry brands due to a possible health risk from Listeria monocytogenes. Listeria monocytogenes is an organism which can cause serious and sometimes fatal […]

U.S. Marshals seize adulterated food from a Minnesota warehouse

June 20, 2017

The U.S. Food and Drug Administration announced that on June 15, the U.S. Marshals Service seized food products held at Professional Warehouse and Distribution, Inc., in St. Paul, Minnesota. The food products seized are worth approximately $73,000 and include, among other things, barley flour, spices, pasta, dried beans, tea and cookies.

House of Thaller Recalls Selected Pine Nut Hummus Products Because of Possible Health Risk

June 20, 2017

House of Thaller, a Knoxville Tennessee company, is voluntarily recalling selected 10 ounce packages of Hummus with Pine Nut Topping, because an ingredient supplier notified us that their ingredient has the potential to be contaminated with Listeria monocytogenes. Read The Complete Story!

Recall Expansion in New Jersey on Fewer than 650 units of Ava’s Brand Organic Roasted Unsalted Cashews and Organic Roasted Unsalted Almonds

June 20, 2017

Hampton Farms is expanding its voluntary recall to include Ava’s Brand Organic Roasted Unsalted Cashews and Ava’s Brand Organic Roasted Unsalted Almonds distributed only in New Jersey. This is the result of a recall expansion from Hampton Farms’ supplier, Hudson Valley Foods, Inc. of Highland, NY advising Hampton Farms that ingredients sold to the company […]

Home | Copyright 2008-2024 FoodandDrugRecall.org